An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice
2011

Oral Vaccine Based on U-Omp19 Protects Mice Against Brucella Infection

Sample size: 5 publication 10 minutes Evidence: high

Author Information

Author(s): Pasquevich Karina A., Ibañez Andrés E., Coria Lorena M., García Samartino Clara, Estein Silvia M., Zwerdling Astrid, Barrionuevo Paula, Oliveira Fernanda S., Seither Christine, Warzecha Heribert, Oliveira Sergio C., Giambartolomei Guillermo H., Cassataro Juliana

Primary Institution: Universidad de Buenos Aires (UBA), Buenos Aires, Argentina

Hypothesis

Can an oral vaccine based on U-Omp19 induce protection against Brucella abortus infection in mice?

Conclusion

The study found that an oral vaccine based on U-Omp19 induces protection against Brucella abortus by eliciting an adaptive IL-17 immune response.

Supporting Evidence

  • U-Omp19 formulations induced protection against Brucella when orally administered without the need of adjuvants.
  • IL-17A neutralization during the challenge period abrogated the vaccine's protective effect.
  • U-Omp19 activated dendritic cells in vivo, indicating its potential as a self-adjuvant.

Takeaway

Researchers created a vaccine from a protein called U-Omp19 that can be given to mice by mouth, and it helps them fight off a type of bacteria that can make them sick.

Methodology

Mice were immunized with U-Omp19 via oral and parenteral routes, and their immune responses were evaluated after challenging them with virulent Brucella.

Limitations

The study was conducted in mice, and results may not directly translate to other species.

Participant Demographics

8-10 week-old female specific-pathogen-free mice.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0016203

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication